BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24280221)

  • 1. Neuroprotective role of the basic leucine zipper transcription factor NFIL3 in models of amyotrophic lateral sclerosis.
    Tamai S; Imaizumi K; Kurabayashi N; Nguyen MD; Abe T; Inoue M; Fukada Y; Sanada K
    J Biol Chem; 2014 Jan; 289(3):1629-38. PubMed ID: 24280221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel abnormalities are consistent with early axon degeneration of motor axons in the G127X SOD1 mouse model of amyotrophic lateral sclerosis.
    Maglemose R; Hedegaard A; Lehnhoff J; Dimintiyanova KP; Moldovan M; Grøndahl L; Meehan CF
    Exp Neurol; 2017 Jun; 292():154-167. PubMed ID: 28322742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific induction of Akt3 in spinal cord motor neurons is neuroprotective in a mouse model of familial amyotrophic lateral sclerosis.
    Peviani M; Tortarolo M; Battaglia E; Piva R; Bendotti C
    Mol Neurobiol; 2014 Feb; 49(1):136-48. PubMed ID: 23873136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.
    Larrodé P; Calvo AC; Moreno-Martínez L; de la Torre M; Moreno-García L; Molina N; Castiella T; Iñiguez C; Pascual LF; Mena FJM; Zaragoza P; Y Cajal SR; Osta R
    Mol Neurobiol; 2018 Jan; 55(1):1-12. PubMed ID: 28840473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis.
    Huang G; Lee X; Bian Y; Shao Z; Sheng G; Pepinsky RB; Mi S
    Cell Death Dis; 2013 Oct; 4(10):e841. PubMed ID: 24113175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.
    Fallini C; Bassell GJ; Rossoll W
    Hum Mol Genet; 2012 Aug; 21(16):3703-18. PubMed ID: 22641816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosis.
    Peters OM; Millership S; Shelkovnikova TA; Soto I; Keeling L; Hann A; Marsh-Armstrong N; Buchman VL; Ninkina N
    Neurobiol Dis; 2012 Oct; 48(1):124-31. PubMed ID: 22750530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
    Ditsworth D; Maldonado M; McAlonis-Downes M; Sun S; Seelman A; Drenner K; Arnold E; Ling SC; Pizzo D; Ravits J; Cleveland DW; Da Cruz S
    Acta Neuropathol; 2017 Jun; 133(6):907-922. PubMed ID: 28357566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAK4 suppresses motor neuron degeneration in hSOD1
    Cong C; Liang W; Zhang C; Wang Y; Yang Y; Wang X; Wang S; Huo D; Wang H; Wang D; Feng H
    Cell Prolif; 2021 Apr; 54(4):e13003. PubMed ID: 33615605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peroxisome proliferator-activated receptor γ (PPARγ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis.
    Benedusi V; Martorana F; Brambilla L; Maggi A; Rossi D
    J Biol Chem; 2012 Oct; 287(43):35899-911. PubMed ID: 22910911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting regeneration while blocking cell death preserves motor neuron function in a model of ALS.
    Wlaschin JJ; Donahue C; Gluski J; Osborne JF; Ramos LM; Silberberg H; Le Pichon CE
    Brain; 2023 May; 146(5):2016-2028. PubMed ID: 36342754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Peters OM; Lewis EA; Osterloh JM; Weiss A; Salameh JS; Metterville J; Brown RH; Freeman MR
    Hum Mol Genet; 2018 Nov; 27(21):3761-3771. PubMed ID: 30010873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
    Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
    Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
    Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
    Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.
    Vargas MR; Johnson DA; Sirkis DW; Messing A; Johnson JA
    J Neurosci; 2008 Dec; 28(50):13574-81. PubMed ID: 19074031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.